SRM transitions utilized for the quantification of the unlabeled KRAS peptide were 401 - Discovery and characterization of Histamine-2 Receptor Antagonists

SRM transitions utilized for the quantification of the unlabeled KRAS peptide were 401.86/475.24 (y3+1), 485.23 (y7+2), and 558.76 (y8+2) (Q1/Q3) and the transitions utilized for … Continue reading SRM transitions utilized for the quantification of the unlabeled KRAS peptide were 401